CA2102072A1 - Combination preparation containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence - Google Patents

Combination preparation containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence

Info

Publication number
CA2102072A1
CA2102072A1 CA002102072A CA2102072A CA2102072A1 CA 2102072 A1 CA2102072 A1 CA 2102072A1 CA 002102072 A CA002102072 A CA 002102072A CA 2102072 A CA2102072 A CA 2102072A CA 2102072 A1 CA2102072 A1 CA 2102072A1
Authority
CA
Canada
Prior art keywords
morphine
flupirtin
pain
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002102072A
Other languages
French (fr)
Other versions
CA2102072C (en
Inventor
Bernd Nickel
Michael Lobisch
Stefan Szelenyi
Jurgen Engel
Peter Emig
Gabriela Pergande
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2102072A1 publication Critical patent/CA2102072A1/en
Application granted granted Critical
Publication of CA2102072C publication Critical patent/CA2102072C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes

Abstract

The combination of flupirtin and morphine has the property of having a strong analgesic action and of not causing any morphine-like dependence and tolerance. New medicaments containing this active substance combination are described.
CA002102072A 1992-10-30 1993-10-29 Combination preparation containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence Expired - Lifetime CA2102072C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEP4236752.2 1992-10-30
DE4236752A DE4236752A1 (en) 1992-10-30 1992-10-30 Combination preparation of flupirtine and morphine for the treatment of pain and for avoiding morphine addiction

Publications (2)

Publication Number Publication Date
CA2102072A1 true CA2102072A1 (en) 1994-05-01
CA2102072C CA2102072C (en) 2005-01-04

Family

ID=6471783

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002102072A Expired - Lifetime CA2102072C (en) 1992-10-30 1993-10-29 Combination preparation containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence

Country Status (11)

Country Link
US (1) US5521178A (en)
EP (1) EP0595311B1 (en)
JP (1) JP3665354B2 (en)
AT (1) ATE147979T1 (en)
BR (1) BR9304431A (en)
CA (1) CA2102072C (en)
DE (2) DE4236752A1 (en)
DK (1) DK0595311T3 (en)
ES (1) ES2099344T3 (en)
GR (1) GR3022995T3 (en)
HU (1) HU219907B (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL119660A (en) * 1993-05-10 2002-09-12 Euro Celtique Sa Controlled release formulation comprising tramadol
KR100354702B1 (en) 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 Manufacturing method and sustained release composition of pharmaceutical composition
US5891471A (en) 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
US5843480A (en) 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19918325A1 (en) 1999-04-22 2000-10-26 Euro Celtique Sa Extruded drug dosage form, e.g. granulate for tableting, comprising an active agent in a polysaccharide-containing matrix, giving a release profile which is controllable by extrusion conditions and/or the inclusion of additives
WO2001008682A2 (en) * 1999-08-03 2001-02-08 Awd.Pharma Gmbh & Co. Kg Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats
AU2004298288B2 (en) * 2003-12-16 2011-06-30 Relevare Aust. Pty Ltd Methods and compositions
CA2550023C (en) * 2003-12-16 2011-04-12 Cnsbio Pty Ltd Treatment of neuropathic pain
US7553858B2 (en) * 2003-12-17 2009-06-30 Meda Pharma Gmbh & Co. Kg Combination of flupirtine and tramadol
US20060052370A1 (en) * 2004-08-24 2006-03-09 Meyerson Laurence R Methods and compositions for treating nociceptive pain
US7619007B2 (en) 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
EP1688141A1 (en) 2005-01-31 2006-08-09 elbion AG The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
WO2006121560A2 (en) 2005-04-06 2006-11-16 Adamas Pharmaceuticals, Inc. Methods and compositions for treatment of cns disorders
US20070042054A1 (en) * 2005-04-20 2007-02-22 Council Of Scientific And Industrial Research Functional aphrodisiac rolled herbal bidis and cigarettes
BRPI0719591B1 (en) * 2006-11-28 2018-07-31 Purac Biochem B.V. Method for the production of stable lactide particles and the use of said particles
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
US20120059024A1 (en) * 2009-01-30 2012-03-08 Relevare Aust. Pty Ltd Drug abuse deterrent, methods and compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI855016A (en) * 1985-06-28 1986-12-29 Degussa SYNERGISTIC COMBINATION AV FLUPIRTIN OCH 4-ACETAMIDO-PHENOL.

Also Published As

Publication number Publication date
EP0595311B1 (en) 1997-01-22
DK0595311T3 (en) 1997-05-26
CA2102072C (en) 2005-01-04
HU9303089D0 (en) 1994-01-28
HU219907B (en) 2001-09-28
ATE147979T1 (en) 1997-02-15
JP3665354B2 (en) 2005-06-29
DE4236752A1 (en) 1994-05-05
JPH06211663A (en) 1994-08-02
DE59305236D1 (en) 1997-03-06
EP0595311A1 (en) 1994-05-04
BR9304431A (en) 1994-06-07
ES2099344T3 (en) 1997-05-16
HUT66085A (en) 1994-09-28
US5521178A (en) 1996-05-28
GR3022995T3 (en) 1997-07-30

Similar Documents

Publication Publication Date Title
CA2102072A1 (en) Combination preparation containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence
AU5171293A (en) Ion-pairing of drugs for improved efficacy and delivery
GB9016789D0 (en) Medicament administering devices
HUP9900028A3 (en) Pharmaceutically active quinazoline compounds, their production, use thereof and medicament containing them
AU4227793A (en) Drug infuser
AU7545594A (en) Implantable device for the treatment of aedemas
GB9410236D0 (en) Cytotoxic drug therapy
IL112029A (en) Raloxifine and related compounds for use as medicaments for the treatment of disorders associated with an excess of tachykinin
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
AU4705193A (en) Medicaments for the treatment or prevention of elevated intraocular pressure
EP0676963A4 (en) Hyaluronic acid-urea pharmaceutical compositions and uses.
HU9700060D0 (en) New compound, it's production and it's use as active component of a medicine
CA2118512A1 (en) Agents for treating substance abuse disorders
CA2190837A1 (en) Transdermal delivery of anti-epileptic drugs
EP0592903A3 (en) Use of ancrod for the preparation of drugs for the treatment of restenosis.
EP0586812A3 (en) Medicaments comprising glicentin as active ingredient.
GB9410237D0 (en) Inactivation of cytotoxic drugs
AU8268491A (en) Phosphonopyrrolidine- and piperidine-containing pseudopeptides of the statin type, a process for their preparation and their use as medicaments against retroviruses
ZA975168B (en) Devices intended for the transdermic administration of trimegestone their preparation process and their use as medicaments
ZA932450B (en) Drugs for the treatment of diabetes
AU7654094A (en) Microparticles, processes for their preparation and their use for the preparation of medicaments
AU3753895A (en) Tetrahydroisoquinoline derivative and medicinal preparation containing the same
AU3526193A (en) Dosage aerosols containing the active substance flezelastin and related structures
AU665052B2 (en) The use of a compound for the manufacture of a medicament for the treatment of HIV infection
CA2233677A1 (en) A novel combination of a .beta.-receptor blocker and an opioid

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20131029